Literature DB >> 12393169

Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum.

Gunter Kenis1, Charlotte Teunissen, Raf De Jongh, Eugène Bosmans, Harry Steinbusch, Michael Maes.   

Abstract

The stability of interleukin 6 (IL-6), its soluble receptor (sIL-6R), IL-10 and CC16 or uteroglobin (an endogenous cytokine inhibitor) in human serum was examined using an accelerated stability testing protocol according to the Arrhenius equation. Further, the effect of time delay between blood sampling and sample processing, clotting temperature and repeated freeze-thaw cycles on serum levels of these proteins were determined. Paired serum samples were stored at 4 degrees C, 20 degrees C, 30 degrees C and 40 degrees C for 1 to 21 days. We found that IL-6 and CC16 concentrations did not change at 4 degrees C, 20 degrees C and 30 degrees C. Interleukin-6 concentrations significantly declined after 11 days at 40 degrees C. The concentrations of sIL-6R and IL-10 did not change at 4 degrees C but significantly decreased at 20 degrees C (after 21 and 14 days respectively), 30 degrees C and 40 degrees C (after 1 day at both temperatures for both cytokines). Arrhenius-plots indicated that sIL-6R and IL-10 are stable for at least several years at -20 degrees C and -70 degrees C, respectively. Since their relative stability, no Arrhenius-plot could be calculated for IL-6 and CC16. The concentrations of the proteins examined were not significantly altered by repeated freeze-thaw cycles, nor by extended clotting times at 4 degrees C or 20 degrees C. We conclude that serum samples for the determination of IL-6, sIL-6R and CC16 can be stored at -20 degrees C for several years, but for IL-10 determinations, storage at -70 degrees C is recommended.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393169

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

1.  A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.

Authors:  Nrupen A Bhavsar; Jay H Bream; Alan K Meeker; Charles G Drake; Sarah B Peskoe; Djeneba Dabitao; Angelo M De Marzo; William B Isaacs; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-22       Impact factor: 4.254

2.  "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Authors:  Peter A Kavsak; Dennis T Ko; Alice M Newman; Glenn E Palomaki; Viliam Lustig; Andrew R Macrae; Allan S Jaffe
Journal:  Clin Chim Acta       Date:  2007-10-03       Impact factor: 3.786

3.  Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.

Authors:  Charles S Morrison; Pai-Lien Chen; Hidemi Yamamoto; Xiaoming Gao; Tsungai Chipato; Sharon Anderson; Robert Barbieri; Robert Salata; Gustavo F Doncel; Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.731

4.  Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth.

Authors:  Gila I Neta; Ondine S von Ehrenstein; Lynn R Goldman; Kirsten Lum; Rajeshwari Sundaram; William Andrews; Jun Zhang
Journal:  Am J Epidemiol       Date:  2010-03-26       Impact factor: 4.897

5.  Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.

Authors:  Stefano Guerra; Marilyn Halonen; Monica M Vasquez; Amber Spangenberg; Debra A Stern; Wayne J Morgan; Anne L Wright; Iris Lavi; Lluïsa Tarès; Anne-Elie Carsin; Carlota Dobaño; Esther Barreiro; Jan-Paul Zock; Jesús Martínez-Moratalla; Isabel Urrutia; Jordi Sunyer; Dirk Keidel; Medea Imboden; Nicole Probst-Hensch; Jenny Hallberg; Erik Melén; Magnus Wickman; Jean Bousquet; Danielle C M Belgrave; Angela Simpson; Adnan Custovic; Josep M Antó; Fernando D Martinez
Journal:  Lancet Respir Med       Date:  2015-07-06       Impact factor: 30.700

Review 6.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

7.  Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease.

Authors:  Kwaku Asare; Beatrice E Gee; Jonathan K Stiles; Nana O Wilson; Adel Driss; Alexander Quarshie; Robert J Adams; Abdullah Kutlar; Jacqueline M Hibbert
Journal:  Cytokine       Date:  2009-11-08       Impact factor: 3.861

8.  A trial assessing N-3 as treatment for injury-induced cachexia (ATLANTIC trial): does a moderate dose fish oil intervention improve outcomes in older adults recovering from hip fracture?

Authors:  Michelle D Miller; Alison Yaxley; Anthony Villani; Lynne Cobiac; Robert Fraser; Leslie Cleland; Michael James; Maria Crotty
Journal:  BMC Geriatr       Date:  2010-10-22       Impact factor: 3.921

Review 9.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

10.  Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.

Authors:  Linda K Ellertsen; Dag G Storla; Lien M Diep; Karl A Brokstad; Harald G Wiker; Geir Hetland
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.